Manish Goel
About Manish Goel
SEBI Registered Investment Adviser • Chartered Accountant
423 Articles Published
Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
May 22, 2026
The CEO-to-Median-Employee Pay Ratio mandated by Companies Act Section 197(12) read with Rule 5(1)(i) is one of the highest signal-to-noise governance disclosures in any Indian annual report. This educational piece decodes the metric, shows how to read its three-to-five-year arc, and illustrates the disciplined Pattern-A signature using Titan Biotech (BSE: 524717) FY25 audited markers — purely as a teaching case, not as a buy/sell view.
May 22, 2026
Christopher Mayer's 365-stock empirical study extracted seven attributes that predicted 100x compounders. Titan Biotech FY25 illustrates five of the seven on a small-cap Indian balance sheet.
May 21, 2026
Roy Baumeister and colleagues showed in 2001 that bad events register roughly three times more strongly than good ones in the human mind. For Indian retail investors, this asymmetry explains panic selling, F&O double-downs, SIP discontinuations during drawdowns and the weight of a single negative headline. Includes Titan Biotech Ltd (BSE: 524717) FY25 audited educational case study.
May 21, 2026
How to read an Indian listed company's Audit Committee disclosure in 5 minutes — composition, financial-literacy, meeting-cadence, attendance and terms-of-reference tests, illustrated with Titan Biotech FY25 audited governance markers.
